Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rheumatology | 6 | 2023 | 138 | 1.780 |
Why?
|
| Arthritis, Juvenile | 4 | 2023 | 58 | 1.670 |
Why?
|
| Teratogens | 1 | 2023 | 92 | 0.830 |
Why?
|
| Pregnancy in Adolescence | 1 | 2023 | 61 | 0.820 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2024 | 257 | 0.800 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 3 | 2022 | 76 | 0.510 |
Why?
|
| Biomedical Research | 1 | 2022 | 800 | 0.470 |
Why?
|
| Pediatrics | 1 | 2022 | 1189 | 0.410 |
Why?
|
| Immunosuppressive Agents | 6 | 2022 | 1431 | 0.360 |
Why?
|
| Immunoglobulins, Intravenous | 4 | 2022 | 191 | 0.320 |
Why?
|
| Lupus Nephritis | 2 | 2017 | 56 | 0.240 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 1129 | 0.230 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 234 | 0.230 |
Why?
|
| Mycophenolic Acid | 2 | 2017 | 153 | 0.220 |
Why?
|
| Economics, Behavioral | 1 | 2023 | 9 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 1585 | 0.210 |
Why?
|
| Contraception | 1 | 2023 | 63 | 0.200 |
Why?
|
| Lymphedema | 1 | 2004 | 239 | 0.190 |
Why?
|
| Histoplasmosis | 1 | 2021 | 77 | 0.180 |
Why?
|
| Health Equity | 1 | 2022 | 59 | 0.180 |
Why?
|
| Stomatitis, Aphthous | 1 | 2020 | 6 | 0.180 |
Why?
|
| Pharyngitis | 1 | 2020 | 47 | 0.180 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 365 | 0.180 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 230 | 0.180 |
Why?
|
| Rheumatic Diseases | 1 | 2021 | 100 | 0.180 |
Why?
|
| Lymphadenitis | 1 | 2020 | 42 | 0.170 |
Why?
|
| Hodgkin Disease | 1 | 2008 | 1485 | 0.170 |
Why?
|
| Kidney Diseases | 1 | 2004 | 694 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 4480 | 0.160 |
Why?
|
| Pneumococcal Vaccines | 1 | 2020 | 183 | 0.150 |
Why?
|
| Quality Improvement | 2 | 2023 | 914 | 0.150 |
Why?
|
| Pneumococcal Infections | 1 | 2020 | 299 | 0.140 |
Why?
|
| Fever | 1 | 2020 | 521 | 0.140 |
Why?
|
| Documentation | 1 | 2018 | 213 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 1042 | 0.130 |
Why?
|
| Child | 11 | 2023 | 30568 | 0.120 |
Why?
|
| Electronic Health Records | 2 | 2020 | 850 | 0.120 |
Why?
|
| Vaccination | 1 | 2020 | 1164 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 565 | 0.110 |
Why?
|
| Humans | 19 | 2024 | 270880 | 0.100 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 146 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 5002 | 0.100 |
Why?
|
| Hydroxychloroquine | 1 | 2011 | 31 | 0.090 |
Why?
|
| Adolescent | 5 | 2024 | 32770 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2004 | 5441 | 0.090 |
Why?
|
| Oligonucleotides | 1 | 2011 | 242 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2013 | 392 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2013 | 508 | 0.080 |
Why?
|
| Pregnancy | 1 | 2023 | 8127 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 1301 | 0.080 |
Why?
|
| Sialyltransferases | 1 | 2008 | 29 | 0.080 |
Why?
|
| Etanercept | 1 | 2008 | 68 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2022 | 505 | 0.080 |
Why?
|
| Algorithms | 1 | 2020 | 3900 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 878 | 0.080 |
Why?
|
| Infliximab | 1 | 2008 | 138 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 207 | 0.070 |
Why?
|
| Patient Participation | 1 | 2022 | 453 | 0.070 |
Why?
|
| Consensus | 1 | 2022 | 1105 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2022 | 1035 | 0.070 |
Why?
|
| Rituximab | 1 | 2011 | 1593 | 0.060 |
Why?
|
| Remission Induction | 1 | 2012 | 3652 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2008 | 375 | 0.060 |
Why?
|
| Age of Onset | 2 | 2020 | 853 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2004 | 100 | 0.060 |
Why?
|
| Female | 7 | 2024 | 149029 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 824 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2011 | 3244 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 1496 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2021 | 17059 | 0.050 |
Why?
|
| Cimetidine | 1 | 2020 | 28 | 0.040 |
Why?
|
| Pedigree | 1 | 2004 | 2042 | 0.040 |
Why?
|
| Antipyretics | 1 | 2020 | 10 | 0.040 |
Why?
|
| Colchicine | 1 | 2020 | 69 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 763 | 0.040 |
Why?
|
| Tubulin Modulators | 1 | 2020 | 65 | 0.040 |
Why?
|
| Retreatment | 1 | 2021 | 447 | 0.040 |
Why?
|
| Nursing Staff | 1 | 2020 | 14 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2008 | 2166 | 0.040 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 58 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2023 | 354 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2020 | 82 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 83 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 3408 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 1558 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 97 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 196 | 0.040 |
Why?
|
| Tonsillectomy | 1 | 2020 | 119 | 0.040 |
Why?
|
| Infant | 2 | 2018 | 13997 | 0.040 |
Why?
|
| Base Sequence | 1 | 2004 | 5437 | 0.040 |
Why?
|
| Rheumatologists | 1 | 2017 | 12 | 0.040 |
Why?
|
| Nephrologists | 1 | 2017 | 14 | 0.040 |
Why?
|
| Neck | 1 | 2020 | 395 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 3215 | 0.040 |
Why?
|
| Pediatricians | 1 | 2017 | 65 | 0.030 |
Why?
|
| Young Adult | 3 | 2024 | 22245 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 1407 | 0.030 |
Why?
|
| DNA | 1 | 2004 | 3051 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 418 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 658 | 0.030 |
Why?
|
| Male | 6 | 2021 | 128463 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 5779 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 264 | 0.030 |
Why?
|
| United States | 2 | 2022 | 15864 | 0.030 |
Why?
|
| Research Design | 1 | 2022 | 1569 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 436 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2020 | 822 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 829 | 0.030 |
Why?
|
| Echocardiography | 1 | 2018 | 1228 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 5465 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2395 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 4831 | 0.020 |
Why?
|
| Australia | 1 | 2008 | 261 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2008 | 494 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 6516 | 0.020 |
Why?
|
| Kidney | 1 | 2013 | 2121 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 4375 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 9290 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 39865 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 33756 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 4645 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 82036 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 17902 | 0.010 |
Why?
|
YILDIRIM TORUNER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_